Navigation Links
Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
Date:3/31/2011

PARSIPPANY, N.J., March 31, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX), an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL™ and established 2011 financial guidance.

"Since our initial public offering in February, we have continued to make significant progress in educating healthcare professionals and other decision makers on the advantages of EXPAREL, including multiple recent data presentations at medical meetings and the formation of several clinical advisory boards led by key opinion leaders," said David Stack, president and chief executive officer of Pacira Pharmaceuticals, Inc.  "We have received encouraging feedback from these health care providers regarding the need for a safe, long-acting, easy to use analgesic to manage postsurgical pain. As we continue to advance our pre-launch strategy, we are planning to conduct a number of health outcomes studies focused on the potential for EXPAREL to control pain with reduced reliance on opioid (morphine) analgesics.  The health outcomes program is designed in collaboration with our acute health care customers in order to define postsurgical patient and procedure needs where reduced opioid (morphine) consumption provides the opportunity for enhanced patient care and hospital economics." 

Financial Highlights

  • Net loss for the quarter ended December 31, 2010 was $7.0 million, or $12.27 per share, compared with $9.0 million, or $15.63 per share, for the quarter ended December 31, 2009. Net loss for the year ended December 31, 2010 was $27.1 million, or $47.29 per share, compared with $31.7 million, or $55.32 per common share, for the year ended December 31, 2009.  In February 2
    '/>"/>

    • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    2. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    3. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    4. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    6. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    7. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    8. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
    9. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
    10. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
    11. Cempra Pharmaceuticals to Present at Two Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... -- DST Health Solutions, LLC (DSTHS), a leading provider ... delivery systems, and health care providers, has announced that ... has jumped significantly. A customizable solution ... medical prescription drug claims, MDMS allows health ... claims processes. As specialty drug demand grows due to ...
    (Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
    (Date:6/19/2013)... -- It may seem like an odd pairing: an oral growth ... were two of the most talked about topics at ENDO ... Expo that just convened in San Francisco ... of the top internal medicine experts in the world is ... can not only save lives, but help people feel and ...
    Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
    ... Keck Graduate Institute,(KGI) today announced that Ian ... has received two grants from the US Department ... to reduce battlefield,fatalities among American military personnel., ... before medics,are able to reach them," said Phillips. ...
    ... leader in the,development of phototherapy treatments for infections, plans ... (onychomycosis) in,2009 upon completion of their current pivotal trials ... states Keraderm CEO Bill Cumbie, "is to develop a ... by a large,number of people at a low cost. ...
    Cached Medicine Technology:KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research 2Keraderm to Release $100 Phototherapy Treatment for Fungal Nail Infections 2
    (Date:6/19/2013)... Arbor, Mich. Children had half as many ... evening office hours on five or more days a ... at C.S. Mott Children,s Hospital and Johns Hopkins University. ... in The Journal of Pediatrics and will ... "These findings are an important step in understanding where ...
    (Date:6/19/2013)... release is available in Spanish . ... of neglected diseases, it goes by the name of the ... was devoted to conditions that accounted for 90 per cent ... imbalance that the Drugs for Neglected Diseases initiative (DNDi) came ... the organization has been granted the BBVA Foundation Frontiers of ...
    (Date:6/19/2013)... encounters are increasingly common on college campuses, but ... "hook up"? A new study by researchers with ... Medicine, published online by the Archives of ... and behaviors associated with sexual hookups, particularly among ... for negative emotional and physical health outcomes as ...
    (Date:6/19/2013)... Abington, PA (PRWEB) June 19, 2013 ... the expertise of neurologists, neurosurgeons, psychiatrists and urologists ... speech pathology. The team works with patients and ... to improve overall quality of life. Patients also ... investigational clinical trials and research. , “Movement disorders ...
    (Date:6/19/2013)... for repairing damage to the genetic material DNA become ... seem, those compounds are sparking optimism as potential treatments ... in BRCA, a gene that made headlines when actress ... termed PARP inhibitors, are the topic of the cover ... Engineering News . C&EN is the weekly news magazine ...
    Breaking Medicine News(10 mins):Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5Health News:Why are some college students more likely to 'hook up'? 2Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2
    ... 2010 Direct-to-consumer (DTC) genetic tests available from retailers ... without going to a doctor, but they raise the ... of these tests. Critics worry about safety risks if ... or misunderstood test results. A group of ...
    ... Chevy Chase, MDUsing novel technology allowing "virtual bone biopsies" ... cancer called androgen deprivation therapy (ADT) is associated with ... has been accepted for publication in The Endocrine Society,s ... Prostate cancer is the second most ...
    ... Cartagena (UPCT) estimate that each pack of cigarettes really costs ... is taken into account. These figures confirm previous studies, and ... policies. "One of the conclusions of the article is ... at a newsstand is only a very small price of ...
    ... Injury Research and Policy at the Johns Hopkins Bloomberg ... million by the Peer Reviewed Orthopaedic Research Program (PRORP) ... its Major Extremity Trauma Research Consortium (METRC). The Consortium, ... of $18 million from DOD, conducts multi-center studies relevant ...
    ... among elderly Nigerians and associated with treatable health conditions like ... research published in the October 2010 issue of Otolaryngology ... million Americans, however, suffer from tinnitus or head noises. It ... in one or both ears. In Nigeria, tinnitus affects between ...
    ... realizes -- in basic biological development and, maybe, they ... to University of Oregon researchers. In a study ... UO Institute of Molecular Biology focused on the developing ... of its eggshell through the exposure to natural colonizing ...
    Cached Medicine News:Health News:Experts say direct-to-consumer genetic tests need innovative oversight 2Health News:Popular prostate cancer treatment associated with bone decay 2Health News:Real price of each pack of cigarettes is more than 100 2Health News:Additional $38M awarded to expand orthopedic trauma care research 2Health News:Tinnitus in the elderly is prevalent and impacts quality of life 2Health News:Gut microbes promote cell turnover by a well-known pathway 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: